Skip to content

Screening guidance updated after long-running trial reports

The revision lowers the starting age for one test and removes another from routine use.

By Dr Amara Nwosu · Health Correspondent

Lagos · 22 Aug 2026, 11:00 UTC · 6 min read

Text size
Screening guidance updated after long-running trial reports
Lagos. Prototype image; the sample edition uses illustrative photography.

A guidance committee revised two screening recommendations — a development that had been building for months in briefing rooms and second-tier committee papers before it surfaced in public this week. Officials involved describe a process that was slower and more contested than the announcement suggested.

The change follows a trial that ran for eleven years. The immediate consequences are narrow. The structural ones are not: the decision commits institutions to a direction that is expensive to reverse, and it does so at a moment when several of the assumptions underneath it are still being tested.

CircaPost spoke to people across three capitals with knowledge of the discussions. Their accounts agree on the sequence of events and diverge on the motive. That gap is itself instructive, and it is the part of the story most likely to matter a year from now.

What comes next is a question of implementation rather than intent. Watch the funding line, the appointments and the first review date — those three signals will say more about durability than any statement issued alongside the announcement.

Sources

  • Guidance document
  • Trial publication

Corrections: none issued. Prototype edition — all stories, people and market data on this site are fictional samples.